Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 6 | BMC Medicine

Fig. 6

From: Mendelian randomization analysis of blood metabolites and immune cell mediators in relation to GVHD and relapse

Fig. 6

Pyridoxate suppresses T cell function in mixed lymphocyte reactions. Percentages of CD69+CD4+ T cells (A) and CD44+CD62L− CD4+ T cells (B) at different concentrations of pyridoxate. C Percentages of PD-1+ CD8.+ T cells at varying concentrations of pyridoxate. Data are represented as mean ± SEM, with n = 4 per group. *P < 0.05; **P < 0.01

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us